S. K. Shore

发表

Scintigraphic imaging of oncogenes with antisense probes: does it make sense?

E. Reddy, L. Malmud, M. Vekemans, 1995, European Journal of Nuclear Medicine.

Neoplastic transformation by the gep oncogene, Gα12, involves signaling by STAT3

N. Dhanasekaran, R. Kumar, S. K. Shore, 2006, Oncogene.

Activated abl oncogenes and apoptosis: differing responses of transformed myeloid progenitor cell lines.

B. Hoffman, D. Liebermann, S. K. Shore, 1996, Blood.

Molecular Cloning of Platelet Factor XI, an Alternative Splicing Product of the Plasma Factor XI Gene*

O. Bagasra, P. Walsh, S. K. Shore, 1998, The Journal of Biological Chemistry.

Tyrosine phosphorylation of C-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of V-Abl-transformed NIH3T3 fibroblasts

S. K. Shore, A. Tsygankov, E. Feshchenko, 1999, Oncogene.

Activated mutant of G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells.

N. Dhanasekaran, S. K. Shore, M. Vara Prasad, 1994, Oncogene.

Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia.

E. Reddy, L. Leopold, S. K. Shore, 1996, Leukemia & lymphoma.

Nucleotide sequence of testis-derived c-abl cDNAs: implications for testis-specific transcription and abl oncogene activation.

E. Reddy, S. K. Shore, C. Oppi, 1987, Proceedings of the National Academy of Sciences of the United States of America.

SRC in human carcinogenesis.

S. K. Shore, Salvatore V Russello, Scott K Shore, 2003, Frontiers in bioscience : a journal and virtual library.

Src in human carcinogenesis.

S. K. Shore, S. Russello, 2003, Frontiers in bioscience : a journal and virtual library.

c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein

S. K. Shore, J. Zhu, 1996, Molecular and cellular biology.

Structural alterations in the carboxyl-terminal domain of the BCRABL gene product activate its fibroblastic transforming potential.

S. K. Shore, M. La Cava, E. P. Reddy, 1994, The Journal of biological chemistry.

Transforming pathways activated by the v-Abl tyrosine kinase

E. Reddy, R. Tantravahi, S. K. Shore, 2002, Oncogene.

Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells.

B. Mirakhur, N. Dhanasekaran, S. K. Shore, 2000, International journal of oncology.

Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias.

E. Reddy, L. Leopold, R. M. Reddy, 1995, Blood.

Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3.

N. Dhanasekaran, S. K. Shore, R. Kumar, 2006, Oncogene.

Src: regulation, role in human carcinogenesis and pharmacological inhibitors.

S. K. Shore, A. Tsygankov, 2004, Current pharmaceutical design.

Folate-Polylysine-Mediated Delivery of a Multiunit Anti-BCR/ABL Ribozyme to BCR/ABL-Transformed 32D Cells

E. Reddy, L. Leopold, R. M. Reddy, 1998 .

Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity.

E. Reddy, S. K. Shore, P. M. Nabissa, 1993, Oncogene.